Zhejiang Medicine (600216.SH) has announced a forecasted increase, expecting a net profit of 1.039-1.246 billion yuan in 2024, an increase of 141.83%-190.01% compared to the previous year.
Zhejiang Medicine (600216.SH) has issued an announcement, the company is expected to achieve a net profit attributable to the parent company in the year of 2024...
Zhejiang Medicine (600216.SH) issued an announcement, stating that the company is expected to achieve a net profit attributable to the owners of the parent company of 1.039 billion to 1.246 billion yuan in 2024. Compared with the same period last year, it will increase by 609.36 million to 816.36 million yuan, a year-on-year increase of 141.83% to 190.01%.
Related Articles
UBS: Gold trading is not considered "extremely crowded" Going to de-dollarization and currency devaluation support the demand for gold asset allocation.
Tianfeng: The current gold-oil ratio is the second highest in history. After the extreme value regression, it is expected that the gold price will peak in 4-5 months.
Tianfeng: "Artificial intelligence +" action accelerates the landing of "AI+ applications". It is recommended to pay attention to XD INC (02400)."
UBS: Gold trading is not considered "extremely crowded" Going to de-dollarization and currency devaluation support the demand for gold asset allocation.
Tianfeng: The current gold-oil ratio is the second highest in history. After the extreme value regression, it is expected that the gold price will peak in 4-5 months.
Tianfeng: "Artificial intelligence +" action accelerates the landing of "AI+ applications". It is recommended to pay attention to XD INC (02400)."
RECOMMEND
